# FDA Inspection 683802 - NAMSA - March 31, 2010

Source: https://www.globalkeysolutions.net/records/fda_inspections/namsa/0c6595f0-4063-4a4b-b4c7-01f577d65a7a
Source feed: FDA_Inspections

> FDA Inspection 683802 for NAMSA on March 31, 2010. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 683802
- Company Name: NAMSA
- Inspection Date: 2010-03-31
- Classification: No Action Indicated (NAI)
- Project Area: Vaccines and Allergenic Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1084597 - 2019-03-27](https://www.globalkeysolutions.net/records/fda_inspections/namsa/ffb33801-1e35-4a94-9f2b-1fab7d50d838)
- [FDA Inspection 1026806 - 2017-09-15](https://www.globalkeysolutions.net/records/fda_inspections/namsa/5abc5551-e861-4bcf-9d19-1b527ab5d954)
- [FDA Inspection 1026806 - 2017-09-15](https://www.globalkeysolutions.net/records/fda_inspections/namsa/f0cc42ba-d14f-4f42-ad25-9ccbd45b9421)
- [FDA Inspection 904618 - 2014-06-11](https://www.globalkeysolutions.net/records/fda_inspections/namsa/0f62c0a6-6d53-48b8-aed4-c102a647c412)
- [FDA Inspection 788447 - 2012-04-05](https://www.globalkeysolutions.net/records/fda_inspections/namsa/ea5777f5-48e5-491b-bb2d-ebe4a283d679)

Company: https://www.globalkeysolutions.net/companies/namsa/75e0a630-1969-447d-8b12-7ed05ebc324f

Office: https://www.globalkeysolutions.net/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d